Comparison Between Etest and Broth Microdilution Methods for Testing Itraconazole-Resistant Aspergillus fumigatus Susceptibility to Antifungal Combinations
- PMID: 28994001
- DOI: 10.1007/s11046-017-0208-7
Comparison Between Etest and Broth Microdilution Methods for Testing Itraconazole-Resistant Aspergillus fumigatus Susceptibility to Antifungal Combinations
Abstract
The checkerboard broth microdilution assay (BMD) is the most frequently used method for the in vitro evaluation of drug combinations. However, its use to evaluate the effect of antifungal drugs on filamentous fungi is sometimes associated with endpoint-reading difficulties, and different degrees of interaction are assigned to the same drug combination. We evaluated combinations of the azoles, itraconazole, posaconazole, and voriconazole, with the echinocandins, anidulafungin, caspofungin, and micafungin, against 15 itraconazole-resistant Aspergillus fumigatus clinical strains via the checkerboard BMD and Etest assay. Readings after 24 and 48 h, considering the two reading endpoints, the minimum inhibitory concentration (MIC) and minimum effective concentration (MEC), were performed for both methods. Our results showed that the correlation coefficients between the BMD and Etest methods were quite diverse to the drug combinations tested. The highest correlation coefficients of the Etest with the BMD assays (MEC and MIC reading) were the Etest-MIC reading at 24 h and the Etest-MEC reading at 48 h. Improvements in experimental conditions may increase the correlation between the two methods and ensure that Etest assay can be safely used in the evaluation of antifungal combinations against Aspergillus species.
Keywords: Antifungal combinations; Aspergillus fumigatus; Broth microdilution; Etest.
Similar articles
-
Comparative evaluation of different gradient diffusion tests for detection of azole resistance in Aspergillus fumigatus.Diagn Microbiol Infect Dis. 2018 May;91(1):52-54. doi: 10.1016/j.diagmicrobio.2018.01.003. Epub 2018 Jan 9. Diagn Microbiol Infect Dis. 2018. PMID: 29422272
-
Establishing in vitro-in vivo correlations for Aspergillus fumigatus: the challenge of azoles versus echinocandins.Antimicrob Agents Chemother. 2008 Oct;52(10):3504-11. doi: 10.1128/AAC.00190-08. Epub 2008 Jul 21. Antimicrob Agents Chemother. 2008. PMID: 18644959 Free PMC article.
-
In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Aspergillus spp. determined by CLSI and EUCAST broth microdilution methods.Antimicrob Agents Chemother. 2011 Nov;55(11):5155-8. doi: 10.1128/AAC.00570-11. Epub 2011 Aug 15. Antimicrob Agents Chemother. 2011. PMID: 21844312 Free PMC article.
-
Commercial Methods for Antifungal Susceptibility Testing of Saprophytic Molds: Can They Be Used to Detect Resistance?J Fungi (Basel). 2024 Mar 14;10(3):214. doi: 10.3390/jof10030214. J Fungi (Basel). 2024. PMID: 38535222 Free PMC article. Review.
-
[In vitro activity of the echinocandins. How should it be evaluated?].Rev Iberoam Micol. 2005 Sep;22(3):133-40. doi: 10.1016/s1130-1406(05)70026-7. Rev Iberoam Micol. 2005. PMID: 16309347 Review. Spanish.
Cited by
-
Antifungal Susceptibly Testing by Concentration Gradient Strip Etest Method for Fungal Isolates: A Review.J Fungi (Basel). 2019 Nov 22;5(4):108. doi: 10.3390/jof5040108. J Fungi (Basel). 2019. PMID: 31766762 Free PMC article. Review.
-
Synergistic potential of lopinavir and azole combinational therapy against clinically important Aspergillus species.PLoS One. 2024 Dec 2;19(12):e0314474. doi: 10.1371/journal.pone.0314474. eCollection 2024. PLoS One. 2024. PMID: 39621587 Free PMC article.
-
Techniques for the Assessment of In Vitro and In Vivo Antifungal Combinations.J Fungi (Basel). 2021 Feb 4;7(2):113. doi: 10.3390/jof7020113. J Fungi (Basel). 2021. PMID: 33557026 Free PMC article. Review.
-
Challenging fungal infections in cystic fibrosis: a case of mixed Aspergillus species infection and antifungal combination testing.Access Microbiol. 2024 Apr 19;6(4):000758.v3. doi: 10.1099/acmi.0.000758.v3. eCollection 2024. Access Microbiol. 2024. PMID: 38737802 Free PMC article.
-
Evaluation of the Sensititre YeastOne and Etest in Comparison with CLSI M38-A2 for Antifungal Susceptibility Testing of Three Azoles, Amphotericin B, Caspofungin, and Anidulafungin, against Aspergillusfumigatus and Other Species, Using New Clinical Breakpoints and Epidemiological Cutoff Values.Pharmaceutics. 2022 Oct 11;14(10):2161. doi: 10.3390/pharmaceutics14102161. Pharmaceutics. 2022. PMID: 36297597 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources